Roosevelt School Partners with Reagan Presidential Foundation

Roosevelt School partnered with the Reagan Presidential Foundation and Council on Foreign Relations to host a Model Diplomacy Simulation on National Civics Day. High School...

Syracuse Orthopedics Taps LIU Alum for President

Dr. Brett Greenky, ’80, a premier joint replacement surgeon in the United States, is President of Syracuse Orthopedic Specialists. He also serves as the...

LIU Dean’s Research Cited in Campus News

Dr. Rita Langdon (PhD in Information Studies, ’19), Dean of the School of Professional Studies, wrote her dissertation on the pedagogical use of mobile...

Alumna Honored on ‘Top 50 Women Leaders’ List

Salome Jean ’05 was selected to Women We Admire’s Top 50 Women Leaders of New York list. Jean, Chief People & Talent Officer for Big Brothers Big...

LIU Honored for Vaccine Distribution Efforts

Nassau County Executive Laura Curran and the Nassau County Department of Health awarded Long Island University with a citation recognizing its service to the...

Expert Panel Discusses Pressing Global Concerns

Long Island University held a panel discussion featuring three professors from the Brooklyn campus who are nationally recognized experts in their respective fields. The...

Civil Rights Attorney Earns Prominent Leadership Role

Community Legal Services of Philadelphia announced that Cheryl-Lyn Bentley ’08 has been named deputy director of operations and human resources. Her exceptional legal career...

Champion Sharks Selected in Major League Baseball Draft

The Northeast Conference men’s baseball champion Sharks sent shortstop EJ Exposito and right-hand pitcher Joshua Loeschorn to the Major Leagues. Exposito was selected in...

LIU – Top Ranked Theatre Program

Long Island University’s musical theatre program is one of the top 30 in the nation, according to OnStage, a popular online publication that covers...

Weinand Named Chairman at Replimune Group

Dieter Weinand (MS ’87) was appointed Chairman of the Board of Directors at Replimune Group Inc. (REPL), a biotechnology company developing oncolytic immuno-gene therapies....